Literature DB >> 1649555

Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice.

P Schirmacher1, W A Held, D Yang, L Biempica, C E Rogler.   

Abstract

In a major urinary protein (MUP)-promoter/simian virus 40 (SV40)Tag transgenic mouse line (MT-D2) the liver-directed, androgen-regulated transgene expression leads to synchronized pathology resulting in a stepwise progression to multiple hepatocellular carcinomas. SV40Tag-activated replication gives rise to two different preneoplastic alterations in hepatocytes, which are characterized in detail: 1) dysplasia and finally cell death in the original hepatocyte population and 2) amplification of periportal transitional hepatocytes leading to multifocal hyperplasia and hepatocellular carcinoma. Multifocal hyperplasia, most probably the equivalent of SV40Tag-immortalization, grows confluent and leads to hepatomegaly. SV40Tag-independent, secondary events are necessary for the tumor development from confluent hyperplasia. This allows further investigation of the steps involved in malignant transformation and progression during hepatocarcinogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649555      PMCID: PMC1886146     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

Authors:  D M Ornitz; R E Hammer; A Messing; R D Palmiter; R L Brinster
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  An antigenic portrait of the liver during carcinogenesis.

Authors:  D C Hixson; R A Faris; N L Thompson
Journal:  Pathobiology       Date:  1990       Impact factor: 4.342

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Cell cycle regulation of mouse H3 histone mRNA metabolism.

Authors:  R B Alterman; S Ganguly; D H Schulze; W F Marzluff; C L Schildkraut; A I Skoultchi
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

7.  Oncogene-induced liver neoplasia in transgenic mice.

Authors:  E P Sandgren; C J Quaife; C A Pinkert; R D Palmiter; R L Brinster
Journal:  Oncogene       Date:  1989-06       Impact factor: 9.867

8.  Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.

Authors:  R L Brinster; H Y Chen; A Messing; T van Dyke; A J Levine; R D Palmiter
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

9.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

10.  Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA.

Authors:  M Höhne; S Schaefer; M Seifer; M A Feitelson; D Paul; W H Gerlich
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

View more
  9 in total

1.  Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer.

Authors:  Dai Liu; Guangfu Li; Diego M Avella; Eric T Kimchi; Jussuf T Kaifi; Mark P Rubinstein; E Ramsay Camp; Don C Rockey; Todd D Schell; Kevin F Staveley-O'Carroll
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

2.  Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.

Authors:  E Santoni-Rugiu; P Nagy; M R Jensen; V M Factor; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.

Authors:  M Bennoun; M Rissel; N Engelhardt; A Guillouzo; P Briand; A Weber-Benarous
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

4.  Transgenic hepatocarcinogenesis in the rat.

Authors:  J R Hully; Y Su; J K Lohse; A E Griep; C A Sattler; M J Haas; Y Dragan; J Peterson; M Neveu; H C Pitot
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

5.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 6.  Experimental models of hepatocellular carcinoma.

Authors:  Philippa Newell; Augusto Villanueva; Scott L Friedman; Kazuhiko Koike; Josep M Llovet
Journal:  J Hepatol       Date:  2008-01-30       Impact factor: 25.083

7.  [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Authors:  M A Kern; K Breuhahn; M Schuchmann; P Schirmacher
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

8.  Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.

Authors:  Xiaoqiang Qi; Guangfu Li; Dai Liu; Anjan Motamarry; Xiangwei Huang; A Marissa Wolfe; Kristi L Helke; Dieter Haemmerich; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.875

9.  High sensitivity of LEC rats with chronic hepatitis to hepatocarcinogenesis: decreases in unscheduled and replicative DNA synthesis of the hepatocytes.

Authors:  H Sakamoto; N Sawada; Y Kamimura; K Enomoto; M Mori
Journal:  Jpn J Cancer Res       Date:  1993-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.